Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-30 @ 2:04 AM
Study NCT ID:
NCT01123551
Status:
COMPLETED
Last Update Posted:
2014-07-23
First Post:
2010-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain
Sponsor:
University of Monastir
Organization:
Study Overview
Official Title:
Nebulized Morphine Versus Intravenous Morphine in the Management of Post Traumatic Pain in Emergency Department (ED)
Status:
COMPLETED
Status Verified Date:
2014-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In the emergency department, 60% of patients have an acute pain. Appropriate management of acute pain is a public health priority according to who recommendations. Nebulized morphine has been extensively studied in children but less well in adults.
It offers a non-invasive route for systemic drug delivery, more rapid and less invasive than intravenous (IV) method.
It offers a non-invasive route for systemic drug delivery, more rapid and less invasive than intravenous (IV) method.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: